Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Carole Peyssonnaux, … , Victor Nizet, Randall S. Johnson
Carole Peyssonnaux, … , Victor Nizet, Randall S. Johnson
Published July 2, 2007
Citation Information: J Clin Invest. 2007;117(7):1926-1932. https://doi.org/10.1172/JCI31370.
View: Text | PDF
Research Article Article has an altmetric score of 4

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)

  • Text
  • PDF
Abstract

Iron is essential for many biological processes, including oxygen delivery, and its supply is tightly regulated. Hepcidin, a small peptide synthesized in the liver, is a key regulator of iron absorption and homeostasis in mammals. Hepcidin production is increased by iron overload and decreased by anemia and hypoxia; but the molecular mechanisms that govern the hepcidin response to these stimuli are not known. Here we establish that the von Hippel–Lindau/hypoxia-inducible transcription factor (VHL/HIF) pathway is an essential link between iron homeostasis and hepcidin regulation in vivo. Through coordinate downregulation of hepcidin and upregulation of erythropoietin and ferroportin, the VHL-HIF pathway mobilizes iron to support erythrocyte production.

Authors

Carole Peyssonnaux, Annelies S. Zinkernagel, Reto A. Schuepbach, Erinn Rankin, Sophie Vaulont, Volker H. Haase, Victor Nizet, Randall S. Johnson

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 5 9 20 19 23 19 8 21 10 13 18 15 15 21 18 20 23 13 2 292
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2023 (20)

Title and authors Publication Year
The von Hippel-Lindau Tumor Suppressor Gene Mutations Modulate Lipocalin-2 Expression in Ferroptotic-Inflammatory Pathways
Kuo CY, Hsieh PC, Chiu V, Lan CC, Lu KC
Oxidative medicine and cellular longevity 2023
Fighting age-related orthopedic diseases: focusing on ferroptosis
Ru Q, Li Y, Xie W, Ding Y, Chen L, Xu G, Wu Y, Wang F
Bone Research 2023
The role of roxadustat in chronic kidney disease patients complicated with anemia.
Liu J, Yang F, Waheed Y, Li S, Liu K, Zhou X
The Korean Journal of Internal Medicine 2023
β Cell and Autophagy: What Do We Know?
Mohammadi-Motlagh HR, Sadeghalvad M, Yavari N, Primavera R, Soltani S, Chetty S, Ganguly A, Regmi S, Fløyel T, Kaur S, Mirza AH, Thakor AS, Pociot F, Yarani R
Biomolecules 2023
Deficiency in hereditary hemorrhagic telangiectasia-associated Endoglin elicits hypoxia-driven heart failure in zebrafish.
Lelièvre E, Bureau C, Bordat Y, Frétaud M, Langevin C, Jopling C, Kissa K
Disease models & mechanisms 2023
Fibroblast Growth Factor 23 Bone Regulation and Downstream Hormonal Activity.
Clinkenbeard E
Calcified Tissue International 2023
Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice.
Nakai T, Iwamura Y, Kato K, Hirano I, Matsumoto Y, Tomioka Y, Yamamoto M, Suzuki N
Blood Advances 2023
The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
Zhou Q, Mao M, Li J, Deng F
Renal Failure 2023
The effects of intracellular iron availability on the outcome of Toxoplasma gondii infection in mice
Mostafa E, Ahmed FA, Yahia SH, Ibrahim AI, Elbahaie ES
Journal of Parasitic Diseases 2023
LRG1 Associates with Iron Deficiency Anemia Markers in Adolescents
Alhammad R, Abu-Farha M, Rahman A, Thanaraj TA, Shaban L, Alsabah R, Hamad S, Hammad MM, Channanath A, Al-Mulla F, Abubaker J
Nutrients 2023
Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis.
Yan P, Li N, Ma M, Liu Z, Yang H, Li J, Wan C, Gao S, Li S, Zheng L, Waddington JL, Xu L, Zhen X
Signal Transduction and Targeted Therapy 2023
Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism
Jones RB, Silva AD, Ankenbauer KE, Britain CM, Chakraborty A, Brown JA, Ballinger SW, Bellis SL
Glycobiology 2023
Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension
Hopkins CD, Wessel C, Chen O, El-Kersh K, Cave MC, Cai L, Huang J
International journal of biological sciences 2023
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Zhao Y, Xiong W, Li C, Zhao R, Lu H, Song S, Zhou Y, Hu Y, Shi B, Ge J
Signal Transduction and Targeted Therapy 2023
Hypoxia and HIF-1α promote lytic de novo KSHV infection
Lee SC, Naik NG, Tombácz D, Gulyás G, Kakuk B, Boldogkői Z, Hall K, Papp B, Boulant S, Toth Z
Journal of virology 2023
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges.
Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK
Nature reviews. Drug discovery 2023
Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases
Journal of Zhejiang University. Science. B 2023
TGF-β-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer.
Wu J, Liao Q, Zhang LI, Wu S, Liu Z
Oncology research 2023
Myeloid Hif2α is not essential to maintain systemic iron homeostasis.
Jain C, Parimi S, Huang W, Hannifin S, Singhal R, Das NK, Lee KE, Shah YM
Experimental Hematology 2023
Assessing erythroferrone and iron homeostasis in preeclamptic and normotensive pregnancies: A retrospective study
Masoumi Z, Hansson LR, Hansson E, Ahlm E, Mezey E, Erlandsson L, Hansson SR
Placenta 2023

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 14 patents
Highlighted by 1 platforms
288 readers on Mendeley
2 readers on CiteULike
See more details